Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Justice Targets ‘Serious’ GMP Issues, Hears More from Whistleblowers

This article was originally published in The Gold Sheet

Executive Summary

The Justice Department is imposing harsh penalties on manufacturers that commit serious GMP violations and this trend will continue in the foreseeable future. DOJ is also getting more calls from FDA and whistleblowers alleging GMP violations under the False Claims Act.

You may also be interested in...



Experts Suggest Whistleblower Hotlines For Reporting Data Integrity Problems

Pharmaceutical manufacturers need to have whistleblower hotlines in place where employees can anonymously report data integrity problems without fear of reprisal.

Experts Suggest Whistleblower Hotlines For Reporting Data Integrity Problems

Pharmaceutical manufacturers need to have whistleblower hotlines in place where employees can anonymously report data integrity problems. That way there is no fear of reprisal.

Ranbaxy Fraud Settlement Emphasizes Guilty Pleas, Downplays Exclusion

Although pharmaceutical company settlements in the millions of dollars now seem customary, a guilty plea to seven felonies could signal aggressive government pursuit of manufacturing and data integrity concerns.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

OM006922

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel